Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Diseaseswe target
    • Diseases we target
    • Leber Hereditary Optic Neuropathy (LHON)
    • Retinitis Pigmentosa (RP)
    • Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
    • Clinical development Summary
  • Investors
    • Company Overview
    • Financial press releases
    • Investor Newsletters
    • Events & presentations
    • Stock information & Financial agenda
    • Governance
    • Documentation
  • Media

Financial press releases

  • Home >
  • Investors & media >
  • Financial press releases
22 July 2025

GenSight Biologics Announces the Closing of Approximately €500,000 of Additional Financing

17 July 2025

GenSight Biologics Announces Publication on Predictors of Final Visual Outcome in Patients Treated with LUMEVOQ® Gene Therapy

17 July 2025

GenSight Biologics Announces an Additional Financing Amounting to Approximately EUR 500,000 from Existing Shareholder

08 July 2025

GenSight Biologics Reports Cash Position as of June 30, 2025

03 July 2025

GenSight Biologics Announces the Closing of the Company’s c. €4 Million Private Placement

01 July 2025

GenSight Biologics Announces Successful Completion of a Private Placement of Close to EUR 4 Million

26 June 2025

GenSight Biologics Announces Significant Milestone in New Manufacturing Partnership with Catalent

12 June 2025

GenSight Biologics Reaches Agreement with ANSM for Opening of LUMEVOQ® Named Early Access Program (AAC) in France

13 May 2025

GenSight Biologics Announces Approval of All Resolutions Supported by the Board of Directors at the Combined General Meeting of May 13, 2025

23 April 2025

GenSight Biologics Annual General Meeting on May 13, 2025

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 26
  • View next 9 articles
© 2025 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page